Two of the largest private companies in American technology are raising money at the same moment they are preparing to stop being private, and both are doing it at valuations that would rank them among the most valuable public companies in the country. As TechCrunch reported, OpenAI is in talks to raise a $30 billion round at a $1.4 trillion valuation, a round anticipated to be its last before a delayed 2027 public debut. Separately, The Verge reported that Anthropic's forthcoming IPO filing previews mounting losses, leadership proposals to retain power, and warnings that its AI development plans could "further increase the risk that our models cause harm," all as the company eyes a $2 trillion valuation. Meanwhile, a smaller but still substantial winner, EliseAI, has raised $350 million and doubled its valuation to $4 billion, as TechCrunch reported. The single thread running through all three is that late-stage AI capital is now organized around the exit: investors are funding companies not toward a distant future, but toward a specific, dated moment when the public market takes over.
The Last Private Round Is Now a Staging Post
OpenAI's reported $30 billion raise is not a typical growth round. TechCrunch describes it as anticipated to be the company's last before its delayed 2027 public debut. That framing matters for the Funding & Investment beat because it changes what the money is for. A final pre-IPO round is conventionally about bridge capital, a last chance for private investors to buy in before the doors open, and a way to set a public reference price. When the number is $30 billion and the reference valuation is $1.4 trillion, the round stops functioning as a fundraiser and starts functioning as a public-market rehearsal. The company is testing whether private capital will underwrite a valuation that, if realized on an exchange, would make it one of the largest listed American firms by market capitalization. That is a funding decision and an exit strategy in the same transaction, and it is the pattern the other two stories echo in different registers.
Anthropic's Filing Puts Risk Language Into the Capital Stack
The Verge's account of Anthropic's IPO preview adds a second element: the company is reportedly disclosing, in the document meant to attract public shareholders, that its own plans could "further increase the risk that our models cause harm." That is not a routine risk factor template. It is the company telling prospective investors that the growth story and the harm story are the same story. The same preview reportedly details mounting losses and leadership proposals to retain power, even as the company eyes a $2 trillion valuation. For the Funding & Investment beat, the significance is structural rather than moral. A company seeking public capital at that scale has to translate its safety narrative into securities language, and the filing becomes the venue where technical risk is priced. The tension between a $2 trillion target and disclosed losses is not a contradiction inside the filing; it is the central investment question the filing poses to whoever buys the stock.
The Mid-Cap Case Shows the Same Clock
EliseAI's $350 million raise, doubling its valuation to $4 billion in a year, according to TechCrunch, looks like a different kind of story: a vertical AI company, backed by a16z, growing fast and rewarded for it. But the same exit clock is visible. A doubled valuation in twelve months is the kind of step-up that positions a company for a later round or a listing, and the size of the raise suggests investors want enough capital on the balance sheet to reach that point without returning to market. The company is not OpenAI, and it is not Anthropic. It is the proof that the pattern is not confined to the two trillion-dollar names. Capital is concentrating not only in the largest AI companies but in the tier just below them, on the assumption that the public window will eventually open and that the winners will be the ones already funded to wait.
